HER2-Targeted Therapies Summit | June 23-24, 2021 | Virtual Event
Evvnt Promotion / evvnt
Archiv
23.06.2021 - 24.06.2021 Virtual
Time: 8:00 am - 4:30 pm
Kongressthemen
Welcome to the Digital HER2-Targeted Therapies Summit 2021 - The First Conference Focused on Exploring New Frontiers of HER2 as a Pan-Tumor Target
HER2 expressing patients are experiencing drug resistance, suboptimal duration of response and refractory/relapsed disease, stimulating new frontiers for HER2-targeted drug development. Impressive clinical data are being reported for next-generation anti-HER2 approaches in breast, gastric, lung, colon cancers and beyond.
Welcome to the Digital HER2-Targeted Therapies Summit 2021 - The First Conference Focused on Exploring New Frontiers of HER2 as a Pan-Tumor Target
HER2 expressing patients are experiencing drug resistance, suboptimal duration of response and refractory/relapsed disease, stimulating new frontiers for HER2-targeted drug development. Impressive clinical data are being reported for next-generation anti-HER2 approaches in breast, gastric, lung, colon cancers and beyond.
Kongressorganizer (PCO)
Hanson Wade
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/732396-3?pid=4832
Brochure: https://go.evvnt.com/732396-3?pid=4832
Anfragen und Anmeldung:
https://go.evvnt.com/732396-0?pid=4832
Frau Patrycja Kruk
Allgemeinmedizin, Public Health
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
